Physician profile
Kyle Dean Swanson
NPI 1053763664
$8,306.33
in general payments reported to CMS, 2019-2025
25 companies · $808 in 2025
The $808 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,207 · 2020: $459 · 2021: $2,568 · 2022: $535 · 2023: $992 · 2024: $737 · 2025: $808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,252 · Long Term Medical Supply Or Device Loan: $241 · Travel and Lodging: $44.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,251.90 |
| Long Term Medical Supply Or Device Loan | $241.36 |
| Travel and Lodging | $44.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,992.58 | 2019-2025 | Infinity Adaptis, Actishield Cf, Augment Injectable |
| Wardlow Enterprises | $1,200.00 | 2021 | |
| Integra Lifesciences Corporation | $1,085.23 | 2020-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Organogenesis INC. | $725.30 | 2019-2025 | Puraply, Via Matrix |
| Wright Medical Technology, INC. | $652.32 | 2019-2020 | |
| Smith+Nephew, INC. | $369.13 | 2021-2023 | Stravix Pl, Grafix Xc, Stravix |
| Treace Medical Concepts, INC. | $294.60 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $201.13 | 2019-2021 | |
| Carbofix Orthopedics INC | $181.07 | 2023 | |
| Convatec INC. | $132.11 | 2019-2023 | |
| Polynovo North America LLC | $99.77 | 2024-2025 | Novosorb Btm |
| Heron Therapeutics, INC. | $79.84 | 2023 | Zynrelef |
| Kerecis Limited | $45.90 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Sanara Medtech INC. | $43.69 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $24.80 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baudax Bio INC. | $22.71 | 2021 | |
| Paratek Pharmaceuticals, INC. | $21.54 | 2024 | Nuzyra |
| Medline Industries LP | $18.97 | 2020 | |
| Kci USA, INC. | $18.70 | 2022 | |
| Solventum Corporation | $17.96 | 2024 | Activ.A.C. |
| Acera Surgical, INC. | $17.67 | 2021 | |
| Medwest Associates | $17.52 | 2023 | |
| Zimvie INC. | $16.27 | 2023 | |
| Depuy Synthes Sales INC. | $13.91 | 2024 | |
| Orthofix Medical, INC. | $13.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Swanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.